Bart Van der Schueren

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Bariatric Surgery

Cystic Fibrosis

Top Venues

Neurogastroenterology and motility

Case reports in endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Bart Van der Schueren, Patrick Vrijlandt, Andrew Thomson, Heidi Janssen, Kristina Dunder
New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus. Diabetologia (2024)
Nele Mattelaer, Bart Van der Schueren, Lukas Van Oudenhove, Nathalie Weltens, Pieter-Jan Martens
The circulating and central endocannabinoid system in obesity and weight loss. International journal of obesity (2005) (2024)
Bart Van der Schueren, Patrick Vrijlandt, Andrew Thomson, Heidi Janssen, Kristina Dunder
New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus. Diabetologia 67 (7) (2024)
Steenackers N, Gabriël Eksteen, Lucas Wauters, Patrick Augustijns, Bart Van der Schueren, Tim Vanuytsel, Christophe Matthys
Understanding the gastrointestinal tract in obesity: From gut motility patterns to enzyme secretion. Neurogastroenterology and motility 36 (4) (2024)
Ellen Deleus, Matthias Lannoo, Dries Ceulemans, Roland Devlieger, Bart Van der Schueren, Katrien Benhalima
Gestational Weight Gain Following Metabolic Bariatric Surgery: A Scoping Review. Nutrients 16 (15) (2024)
Steenackers N, Gabriël Eksteen, Lucas Wauters, Patrick Augustijns, Bart Van der Schueren, Tim Vanuytsel, Christophe Matthys
Understanding the gastrointestinal tract in obesity: From gut motility patterns to enzyme secretion. Neurogastroenterology and motility 36 (4) (2024)
Nele Steenackers, Thomas Sparsø, Sara Charleer, Christophe E M De Block, Diederik De Cock, Carl Delfin, Chantal Mathieu, Frank Nobels, Sofia Pazmino, Jonathan Rosen, Carmen Hurtado Del Pozo, Pieter Gillard, Bart Van der Schueren
Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONE. Diabetes, obesity & metabolism (2024)
Steenackers N, Gabriël Eksteen, Lucas Wauters, Patrick Augustijns, Bart Van der Schueren, Tim Vanuytsel, Christophe Matthys
Understanding the gastrointestinal tract in obesity: From gut motility patterns to enzyme secretion. Neurogastroenterology and motility (2024)
Ellen Deleus, Matthias Lannoo, Dries Ceulemans, Roland Devlieger, Bart Van der Schueren, Katrien Benhalima
Gestational Weight Gain Following Metabolic Bariatric Surgery: A Scoping Review. Nutrients 16 (15) (2024)
Marie Yskout, Joke Vliebergh, Hakan Bor, J Dupont Lieven, Natalie Lorent, Pascal Van Bleyenbergh, Pieter Gillard, Bart Van der Schueren, Ann Mertens, Chantal Mathieu, Pieter-Jan Martens
Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes. Case reports in endocrinology 2023 (2023)
Marie Yskout, Joke Vliebergh, Hakan Bor, J Dupont Lieven, Natalie Lorent, Pascal Van Bleyenbergh, Pieter Gillard, Bart Van der Schueren, Ann Mertens, Chantal Mathieu, Pieter-Jan Martens
Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes. Case reports in endocrinology 2023 (2023)
Bastiaan Maes, Farzaneh Fayazpour, Leen Catrysse, Guillaume Lornet, Evelien Van De Velde, Caroline De Wolf, Sofie De Prijck, Justine Van Moorleghem, Manon Vanheerswynghels, Kim Deswarte, Benedicte Descamps, Christian Vanhove, Bart Van der Schueren, Pieter-Jan Martens, Hamida Hammad, Sophie Janssens, Bart N Lambrecht
STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity. The Journal of experimental medicine 220 (9) (2023)
Caroline Simoens, Koenraad Philippaert, Caroline Wuyts, Séverine Goscinny, Els Van Hoeck, Joris Van Loco, Jaak Billen, Jan N de Hoon, Els Ampe, Pieter-Jan Martens, Ann Mertens, Rudi Vennekens, Bart Van der Schueren
Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial. European journal of drug metabolism and pharmacokinetics 47 (6) (2022)